Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 3466 AL 3480

Early Detection of Mild Cognitive Impairment (MCI) in Primary Care

Sabbagh MN, Boada M, Borson S, Chilukuri M, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):165-170. doi: 10.14283/jpad.2020.21.

Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials

Rafii MS.

CNS Drugs. 2020 Aug;34(8):785-794. doi: 10.1007/s40263-020-00740-6.

The flash visual evoked potential-P2 and the detection of amnestic mild cognitive impairment: A review of empirical literature

Arruda JE, McInnis MC, Steele J.

Int J Psychophysiol. 2020 Sep;155:162-167. doi: 10.1016/j.ijpsycho.2020.05.012. Epub 2020 Jun 18.

Towards a Redefinition of Cognitive Frailty

Mantovani E, Zucchella C, Schena F, Romanelli MG, Venturelli M, Tamburin S.

J Alzheimers Dis. 2020;76(3):831-843. doi: 10.3233/JAD-200137.

Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression

Rajji TK, Bowie CR, Herrmann N, Pollock BG, Bikson M, Blumberger DM, Butters MA, Daskalakis ZJ, Fischer CE, Flint AJ, Golas AC, Graff-Guerrero A, Kumar S, Lourenco L, Mah L, Ovaysikia S, Thorpe KE, Voineskos AN, Mulsant BH; PACt-MD Study Group.

J Alzheimers Dis. 2020;76(2):733-751. doi: 10.3233/JAD-200141.

Leveraging preclinical models for the development of Alzheimer disease therapeutics

Scearce-Levie K, Sanchez PE, Lewcock JW.

Nat Rev Drug Discov. 2020 Jul;19(7):447-462. doi: 10.1038/s41573-020-0065-9. Epub 2020 Apr 8.

Impaired occipital cerebrovascular reactivity as a biomarker for vascular β-amyloid

Schreiber S, DiFrancesco JC.

Neurology. 2020 Sep 8;95(10):415-416. doi: 10.1212/WNL.0000000000010207. Epub 2020 Jul 8.

Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer's disease

Yoo SJ, Son G, Bae J, Kim SY, Yoo YK, Park D, Baek SY, Chang KA, Suh YH, Lee YB, Hwang KS, Kim Y, Moon C.

Sci Rep. 2020 Jul 8;10(1):11234. doi: 10.1038/s41598-020-68148-2.

Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis

Shigemizu D, Mori T, Akiyama S, Higaki S, Watanabe H, Sakurai T, Niida S, Ozaki K.

Alzheimers Res Ther. 2020 Jul 16;12(1):87. doi: 10.1186/s13195-020-00654-x.

Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid

Wu CY, Bawa KK, Ouk M, Leung N, Yu D, Lanctôt KL, Herrmann N, Pakosh M, Swardfager W.

Ageing Res Rev. 2020 Sep;62:101130. doi: 10.1016/j.arr.2020.101130. Epub 2020 Jul 23.

Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease

Winder Z, Wilcock D, Jicha GA.

Clin Lab Med. 2020 Sep;40(3):289-303. doi: 10.1016/j.cll.2020.05.003.

Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer biomarkers

Arenaza-Urquijo EM, Salvadó G, Operto G, Minguillón C, Sánchez-Benavides G, Crous-Bou M, Grau-Rivera O, Sala-Vila A, Falcón C, Suárez-Calvet M, Zetterberg H, Blennow K, Gispert JD, Molinuevo JL; ALFA Study.

Neurology. 2020 Oct 13;95(15):e2065-e2074. doi: 10.1212/WNL.0000000000010527. Epub 2020 Jul 31.

Visuospatial Memory Alteration in Alzheimer's Disease

Lin S.

Neurosci Bull. 2020 Aug;36(8):829-830. doi: 10.1007/s12264-020-00560-0. Epub 2020 Aug 2.

Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease

Bergland AK, Proitsi P, Kirsebom BE, Soennesyn H, Hye A, Larsen AI, Xu J, Legido-Quigley C, Rajendran L, Fladby T, Aarsland D.

J Alzheimers Dis. 2020;77(3):1117-1127. doi: 10.3233/JAD-200441.

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

Gavrilova SI, Alvarez A.

Med Res Rev. 2021 Sep;41(5):2775-2803. doi: 10.1002/med.21722. Epub 2020 Aug 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias